Adrenocortical mitochondrial proteins

Adrenocortical mitochondrial proteins refer to a collective group of enzymes and associated proteins located within the mitochondria of the adrenal cortex that are essential for steroid hormone biosynthesis (steroidogenesis) [DrugBank DB00648]. This group includes key cytochrome P450 enzymes such as cholesterol side-chain cleavage enzyme (CYP11A1), 11β-hydroxylase (CYP11B1), and aldosterone synthase (CYP11B2), as well as electron transfer proteins like adrenodoxin (FDX1) and adrenodoxin reductase (FDXR) [PMID: 26158620]. These proteins are the primary targets of the adrenolytic drug mitotane, which is used in the treatment of adrenocortical carcinoma and severe Cushing's syndrome [StatPearls NBK542273]. Mitotane is metabolized within the mitochondria to reactive intermediates that bind covalently to these proteins, leading to mitochondrial dysfunction, inhibition of steroid production, and eventual necrosis of the adrenal cortex [PMID: 23446637]. Because this target represents a broad set of proteins rather than a single molecular entity, its pharmacological modulation results in a comprehensive suppression of adrenal steroidogenesis and often necessitates hormone replacement therapy to manage resulting adrenal insufficiency [Wikipedia: Mitotane].

Other names

Adrenal mitochondrial proteinsMitochondrial steroidogenic enzymesAdrenocortical mitochondrial enzymes

Mitotane acts as an adrenolytic agent by undergoing metabolic activation by mitochondrial enzymes to form reactive acyl chloride intermediates [PMID: 23446637]. These intermediates bind covalently to various adrenocortical mitochondrial proteins, causing direct damage to the mitochondrial membranes and inhibiting key steroidogenic enzymes such as CYP11A1 and CYP11B1 [DrugBank DB00648]. This results in the destruction of adrenocortical cells and a profound reduction in the synthesis of cortisol and other adrenal steroids [StatPearls NBK542273].